Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
05/2012
05/24/2012WO2012067963A1 Nampt inhibitors
05/24/2012WO2012066077A1 1,4 di substituted pyrrolidine - 3 - yl -amine derivatives and their use for the treatment of metabolic disorders
05/24/2012WO2012065568A1 Azo heterocyclic compound having insecticidal activity, and preparation and applications thereof
05/24/2012WO2012065527A1 Compouds and uses as l-type calcium channel blocker and/or acetylcholinesterase inhibitor thereof
05/24/2012WO2011051540A8 Androgen receptor modulating compounds
05/24/2012US20120130069 Novel indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredient
05/24/2012US20120129891 Sulfone derivative
05/24/2012US20120129890 Indole derivative or pharmaceutically acceptable salt thereof
05/24/2012US20120129886 Metalloenzyme inhibitor compounds
05/24/2012US20120129870 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor
05/24/2012US20120129863 Chymase inhibitors
05/24/2012US20120129859 Preparation of 1-(substituted benzyl)-5-trifluoromethyl-2(1h)pyridone compounds and salts thereof and their applications
05/24/2012US20120129858 Compounds, compositions and methods comprising pyridazine sulfonamide derivatives
05/24/2012US20120129857 Substituted sodium 1H-pyrazol-5-olate
05/24/2012US20120129856 Compounds, compositions and methods useful for cholesterol mobilisation
05/24/2012US20120129854 Pesticidal Arylpyrrolidines
05/24/2012US20120129851 Substituted Quinazoline and Pyrido-Pyrimidine Derivatives
05/24/2012US20120129848 Benzo [E] [1,3] Oxazin-4-One Derivatives as Phosphoinositide 3-Kinase Inhibitors
05/24/2012US20120129845 Inhibitors of Bruton's Tyrosine Kinase
05/24/2012US20120129844 N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethylpiperazin-1-yl)benzamide and salts thereof
05/24/2012US20120129840 Novel viral replication inhibitors
05/24/2012US20120129837 Derivatives of Fluorene, Anthracene, Xanthene, Dibenzosuberone and Acridine and Uses Thereof
05/24/2012US20120129832 Amide derivative
05/24/2012US20120129831 Substituted 3-(1,2,4-Oxadiazol-5-yl)-5-Phenylpiperidines
05/24/2012US20120129830 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof and therapeutic use thereof
05/24/2012US20120129829 Novel indole modulators of s1p receptors
05/24/2012US20120129812 Novel thyroid hormone beta receptor agonist
05/24/2012US20120128640 Heterocyclic compounds and expansion agents for hematopoietic stem cells
05/24/2012US20120128630 1-(6 members azo-heterocyclic)-pyrrolin-2-one compounds as inhibitors of hepatitis c ns5b polymerase, the pharamaceutical composition thereof and their therapeutic use
05/24/2012US20120126185 Indeno-fused ring compounds
05/24/2012DE102010044131A1 Substituiertes Natrium-1H-pyrazol-5-olat Substituted sodium-1H-pyrazol-5-olate
05/24/2012CA2818025A1 Pyridazine derivatives, compositions and methods for treating cognitive impairment
05/24/2012CA2817093A1 Nampt inhibitors
05/24/2012CA2816594A1 Nampt and rock inhibitors
05/24/2012CA2816144A1 Quinoline derivatives as pik3 inhibitors
05/24/2012CA2814826A1 Bridged spiro[2.4]heptane ester derivatives
05/23/2012EP2454255A1 Pyridin-4-yl derivatives
05/23/2012EP2454254A2 Benzimidazole analogues for the treatment or prevention of flavivirus infections
05/23/2012EP2454253A1 Aminopyridine derivatives for treating tumors and inflammatory diseases
05/23/2012EP2454250A1 Apoptosis signal-regulating kinase inhibitors
05/23/2012EP2454243A2 Tetrazole derivatives
05/23/2012CN1561340B Novel 1,2,4-triazole compound
05/23/2012CN102471330A 用于防治无脊椎动物害虫的哒嗪化合物 For controlling invertebrate pests pyridazine compounds
05/23/2012CN102471329A Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases
05/23/2012CN102471328A 吡啶-4-基衍生物 Pyridin-4-yl derivative
05/23/2012CN102471327A Inhibitors of flaviviridae viruses
05/23/2012CN102471324A 作为丙型肝炎病毒抑制剂的双苯并咪唑衍生物 Bis-benzimidazole derivatives as inhibitors of hepatitis C virus
05/23/2012CN102471321A 用于防治无脊椎动物害虫的哒嗪化合物 For controlling invertebrate pests pyridazine compounds
05/23/2012CN102471317A 用于治疗肿瘤和炎性疾病的氨基吡啶衍生物 For the treatment of cancer and inflammatory diseases aminopyridine derivative
05/23/2012CN102471310A 用于治疗增生性疾病的联吡啶化合物 For the treatment of proliferative diseases bipyridyl compound
05/23/2012CN102471293A Oxazine derivatives and their use as BACE inhibitors for the treatment of neurological disorders
05/23/2012CN102470127A 联芳基化合物和其使用方法 Biaryl compounds and their use
05/23/2012CN102466635A 异噁唑类化合物在氟离子检测中的用途 Isoxazole compounds in the use of fluoride ion detection
05/23/2012CN102464658A 噁唑烷酮衍生物及其制备方法和用途 Oxazolidinone derivatives and their preparation and use
05/23/2012CN102464657A 具有哒嗪或酞嗪母体骨架的含两个噁唑啉的手性双核配体及其合成方法 Two chiral ligand and its dual-core oxazoline containing synthetic methods have pyridazine or phthalazine maternal skeleton
05/23/2012CN102464656A 具有苯并肉啉母体骨架的含两个噁唑啉的手性双核配体及其合成方法 Oxazoline containing two chiral ligands and synthesis of dual-core approach has benzo Cinnoline maternal skeleton
05/23/2012CN102464653A 具有杀虫活性的偶氮杂环化合物、其制备及用途 Azo-heterocyclic compounds having pesticidal activity, their preparation and use
05/23/2012CN102464630A 含氮杂环取代的苯甲酰基类化合物及其应用 Nitrogen-containing heterocyclic compounds substituted benzoyl and Applications
05/23/2012CN102464608A Compound and application thereof as L-calcium channel retarder or/and acetylcholinesterase inhibitor
05/23/2012CN102050819B Oxazolidone derivative as well as preparation method and purposes thereof
05/23/2012CN101921239B Hydrogen di-methyl fluoride substituted isoxazole derivative
05/23/2012CN101805337B Compound containing proline and isoxazole skeleton and preparation method and application thereof
05/23/2012CN101768129B Production intermediate of isoxazoline-substituted benzamide compound
05/23/2012CN101641353B Novel compounds for treatment of psychotic disorders, preparation methods and uses thereof
05/23/2012CN101628888B Inhibitors of cytosolic phospholipase a2
05/23/2012CN101522670B Pyridin-3-yl derivatives as immunomodulating agents
05/23/2012CN101331127B 5-aryl isoxazolines for controlling invertebrate pests
05/23/2012CN101282949B Azole and thiazole derivatives and their use
05/23/2012CN101184738B Purified form of tanaproget
05/23/2012CN101155800B Pyrazolylaminopyridine derivatives useful as kinase inhibitors
05/23/2012CN101061098B Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
05/23/2012CN101014714B Method for the production of diarylcycloalkyl derivatives
05/22/2012US8183383 Protein tyrosine phosphatase 1B inhibitor, preparation methods and uses thereof
05/22/2012US8183368 Thermosetting compound, composition containing the same, and molded article
05/22/2012US8183366 Chemokine receptor antagonists
05/22/2012US8183265 2-adamantyl-butyramide derivatives as selective 11β-HSD1 inhibitors
05/22/2012US8183240 Heteroaryls and uses thereof
05/22/2012US8183238 Bicyclic and tricyclic compounds as KAT II inhibitors
05/22/2012CA2540501C Quinoline derivatives and quinazoline derivatives, medicaments containing said compounds, use thereof, and method for the production thereof
05/18/2012WO2012064973A2 Heterocyclic compounds and uses thereof
05/18/2012WO2012064943A2 Metalloenzyme inhibitor compounds
05/18/2012WO2012064631A1 Pyridyl ureas as mineralocorticoid receptor antagonists
05/18/2012WO2012064603A1 Oxazolidinones as modulators of mglur5
05/18/2012WO2012064559A1 Sgc stimulators
05/18/2012WO2012062783A1 Pyrazole aminopyrimidine derivatives as lrrk2 modulators
05/18/2012WO2012062704A1 Pyridine compounds and aza analogues thereof as tyk2 inhibitors
05/18/2012WO2012062687A1 Triazole derivatives and their use for neurological disorders
05/18/2012WO2012062623A1 Triazole derivatives as ligands for gaba receptors
05/18/2012WO2012062462A1 Substituted heteroaromatic carboxamide and urea derivatives as vanilloid receptor ligands
05/18/2012WO2012027710A3 Compounds that modulate intracellular calcium
05/18/2012WO2012012410A3 Kappa opioid receptor agonists
05/18/2012WO2011139107A3 Picolinamide and pyrimidine-4-carboxamide compounds, process for preparing and phamaceutical composition comprising the same
05/18/2012WO2011077226A8 Procedure for the synthesis of fluorescent probes for metals
05/18/2012CA2817691A1 Metalloenzyme inhibitor compounds
05/18/2012CA2817331A1 Chromene derivatives and their analoga as wnt pathway antagonists
05/18/2012CA2817319A1 Sgc stimulators
05/18/2012CA2816769A1 Substituted heteroaromatic carboxamide and urea derivatives as vanilloid receptor ligands
05/18/2012CA2816753A1 N- sulfonylated tetrahydroquinolines and related bicyclic compounds inhibition of rory activity and the treatment of diseases
05/18/2012CA2815741A1 Triazole derivatives as ligands for gaba receptors
05/18/2012CA2815330A1 Pyridine compounds and aza analogues thereof as tyk2 inhibitors
1 ... 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 ... 647